A detailed history of Horizon Investments, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Horizon Investments, LLC holds 8,176 shares of EW stock, worth $554,005. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,176
Previous 8,282 1.28%
Holding current value
$554,005
Previous $765,000 29.54%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $6,328 - $9,940
-106 Reduced 1.28%
8,176 $539,000
Q2 2024

Aug 09, 2024

BUY
$84.3 - $94.31 $3,034 - $3,395
36 Added 0.44%
8,282 $765,000
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $1,305 - $1,720
-18 Reduced 0.22%
8,246 $787,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $252,702 - $318,427
4,095 Added 98.22%
8,264 $630,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $1,662 - $2,241
-24 Reduced 0.57%
4,169 $288,000
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $55,847 - $64,710
686 Added 19.56%
4,193 $395,000
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $203,175 - $231,219
-2,736 Reduced 43.83%
3,507 $290,000
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $426,396 - $545,887
6,243 New
6,243 $466,000
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $119,456 - $177,140
-1,381 Reduced 21.47%
5,050 $480,000
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $655,704 - $825,354
6,431 New
6,431 $757,000
Q4 2021

Feb 15, 2022

SELL
$106.37 - $130.68 $688,533 - $845,891
-6,473 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $666,136 - $794,560
6,473 New
6,473 $733,000
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $63,320 - $73,169
-1,136 Closed
0 $0
Q1 2019

May 16, 2019

BUY
$47.89 - $64.05 $54,403 - $72,760
1,136 New
1,136 $217,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.